Indeed, coumarins have shown very promising activity in the treatment of neurological disorders, like AD and PD, for their ability to selectively target enzymes involved in neurotransmitter metabolisms, such as AChE and MAO-B, at nanomolar concentrations. The gene discussed is MAOB; the disease is Parkinson disease.